Company / R&D per Share
Nuo Therapeutics, Inc. R&D per Share History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.13
FY2017
5-year range
$0.01 / $0.13
FY2013-FY2017
Trend
+1555.4%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +1555% YoY in FY2017, a notable deviation from the 6-year average annual change of +675%.
Based on SEC 10-K filings.
0.13 in FY2017 with a 5-year CAGR of +17.0%.
Improved from $0.02 to $0.13 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +52.6%
- 5-Year CAGR
- +17.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, r&d per share increased 1555.4% year-over-year.
- Lowest r&d per share in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $0.13 | +1555.4% |
| FY2016 | $0.01 | -60.2% |
| FY2015 | $0.02 | -46.1% |
| FY2014 | $0.04 | -7.0% |
| FY2013 | $0.04 | -33.6% |
| FY2012 | $0.06 | +2640.1% |
| FY2011 | $0.00 | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026